PRKAR2A and colitis: Though the tumour‐promoting roles and mechanisms had not been fully elucidated, our findings strongly revealed that human PRKAR2A‐derived circRNAs might shorten the colitis‐to‐carcinoma process and cause a poor prognosis of CAC patients.